MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
about
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerMAP4K4: an emerging therapeutic target in cancerMAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes.The BRAG/IQSec family of Arf GEFs.Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesisCandidate genetic modifiers of retinitis pigmentosa identified by exploiting natural variation in DrosophilaMap4k4 Signaling Nodes in Metabolic and Cardiovascular DiseasesGLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer.Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signalingFGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway.Endothelial Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Is Critical for Lymphatic Vascular Development and FunctionRole of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells.Non-monotonic cellular responses to heterogeneity in talin protein expression-level.Molecular docking performance evaluated on the D3R Grand Challenge 2015 drug-like ligand datasets.Talin - the master of integrin adhesions.Blocking integrin inactivation as an anti-angiogenic therapy.Tumor cells and their crosstalk with endothelial cells in 3D spheroids.Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis.Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma.Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges.STRIP1, a core component of STRIPAK complexes, is essential for normal mesoderm migration in the mouse embryo.PIPKIγ and talin couple phosphoinositide and adhesion signaling to control the epithelial to mesenchymal transition.CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway.MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.Perturbations of BMP/TGF-β and VEGF/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM)
P2860
Q26774789-B48978FF-8B1D-4B33-B848-46D092EC337EQ28068524-BCDE2E5C-961C-4317-AE85-C152255415BDQ30239799-46058449-FEA9-40E8-BE1C-291FDBA979D9Q30275740-736866E2-7F62-400C-A9CB-84770C66670FQ30804219-EA11D885-739F-4CC8-AD60-09904FF82E12Q36551266-374D2104-2994-43C3-99A1-5EA58EF28B5DQ37018393-1B4C07B8-2F0D-4A83-8710-62BEDDCA209CQ37520347-7E8F6F30-0D7E-41B5-86FA-5E2C91F2CBF7Q37730632-180FE642-FA59-40EC-A097-116BAD5B191FQ38644648-97000FC4-9126-457C-A8D6-FE788025010CQ38780686-AF88C64C-9714-42E4-8469-98256E59FD9AQ38858414-7E3203B1-09C2-48F2-B330-7912476D27BDQ38872068-C706775C-DA9A-4611-8452-A2B1E2B47E51Q39325646-E4C721EF-CCC7-4948-BEAE-3E072DF7A122Q39431307-202A9101-FF94-4AE2-91FD-CFC722F9CF3DQ41392672-8469B6E7-5F44-4FCA-B16B-BF2A9BEE293BQ41621155-B6176896-7530-4EFB-83D2-18974FFEFA37Q41761571-E5FDCBFD-0AF0-493F-A7FF-230590E028AAQ41867931-E6DED43E-C310-4B5F-8641-53D827BC4A30Q47131952-417E11F0-F06F-4FDB-BB37-475D6E8E0EFEQ47332273-8157A9C8-495A-4B35-9ED9-100C194B1B31Q48144836-3B59472E-E86B-4E5D-98F0-C3F17C4EA921Q49308020-371734A8-5392-45ED-9B45-3E4763C12544Q53138552-1ED3A5B9-2965-4F32-9CC2-8E7BCA3FE750Q54978310-A502534E-45AF-41DC-8A10-E085699EE8A2Q58067565-EFDF4EF9-EC78-45CC-8900-2D4758A8A547
P2860
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@en
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@nl
type
label
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@en
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@nl
prefLabel
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@en
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@nl
P2093
P2860
P50
P356
P1433
P1476
MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
@en
P2093
Ailey Crow
Erin McNamara
Jeffrey Eastham-Anderson
Kristina West
Philip Vitorino
Seth F Harris
Stacey Yeung
Stephen Gould
Tanya Smyczek
P2860
P2888
P304
P356
10.1038/NATURE14323
P407
P577
2015-03-18T00:00:00Z
P6179
1010817573